Ni Xiang

This profile gathers the share dealings of Ni Xiang in Kintor Pharmaceutical Ltd. - B, where the filings describe the role as chief executive. The record holds 4 filings, for trades running from 19 March 2024 to 31 March 2026.

In open-market terms, that means 1 purchase on one side and 1 sale on the other. The totals exclude 2 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The record was last updated on 1 April 2026 with a transaction in Kintor Pharmaceutical Ltd. - B. The most recent open-market purchase was published on 29 April 2024, 908 days ago. Filings reach the HKEX feed a median of 6 days after the trade. Until a filing is published, the market cannot know about the trade. This summary is built from HKEX disclosures alone and does not predict where the share price will go.